Regulatory 2022-02-10 | Quarterly Report Q4 2021: Strong data for Orviglance vs. a gadolinium contrast agent PDF Report Presentation Webcast
Regulatory 2021-11-30 | Nomination Committee appointed for AGM 2022 in Ascelia Pharma AB PDF Report Presentation Webcast
Regulatory 2021-11-04 | Quarterly Report Q3 2021: Oncoral – entering clinical collaboration PDF Report Presentation Webcast
Regulatory 2021-05-12 | Quarterly Report Q1 2021: US office opened in preparation of launch PDF Report Presentation Webcast
Regulatory 2021-05-05 | Bulletin from the Annual General Meeting in Ascelia Pharma AB on 5 May 2021 PDF Report Presentation Webcast
Regulatory 2021-04-15 | Ascelia Pharma AB publishes prospectus regarding admission to trading of newly issued shares on Nasdaq Stockholm PDF Report Presentation Webcast
Regulatory 2021-04-13 | Bulletin from the extraordinary general meeting in Ascelia Pharma AB PDF Report Presentation Webcast
Regulatory 2021-04-09 | Issue and repurchase of series C shares for share saving program PDF Report Presentation Webcast
Regulatory 2021-03-31 | NOTICE OF ANNUAL GENERAL MEETING IN ASCELIA PHARMA AB PDF Report Presentation Webcast
Regulatory 2021-03-17 | Notice of extraordinary general meeting in Ascelia Pharma PDF Report Presentation Webcast
Regulatory 2021-02-16 | Quarterly Report Q4 2020: Mangoral shows high diagnostic value in new study PDF Report Presentation Webcast
Regulatory 2020-11-05 | Quarterly Report Q3-2020: Raised market estimate for Mangoral and preparing for market launch PDF Report Presentation Webcast
Regulatory 2020-05-13 | Interim Financial Report Q1-2020: First patient enrolled in Phase 3 study SPARKLE PDF Report Presentation Webcast
Regulatory 2020-05-06 | Bulletin from the Annual General Meeting in Ascelia Pharma AB on 6 May 2020 PDF Report Presentation Webcast
Regulatory 2020-04-03 | Ascelia Pharma’s Nomination Committee proposes election of Lauren Barnes to the Board of Directors PDF Report Presentation Webcast
Regulatory 2020-04-03 | NOTICE OF ANNUAL GENERAL MEETING IN ASCELIA PHARMA AB PDF Report Presentation Webcast
Regulatory 2020-03-02 | Issue and repurchase of series C shares for share saving program PDF Report Presentation Webcast
Regulatory 2020-02-14 | 2019 year-end financial report: Sites opened for recruitment to the pivotal Phase III study SPARKLE PDF Report Presentation Webcast
